Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

CME-Certified Microlearning Platform Successful in Improving Knowledge on the Use of Preventive Migraine Therapies Among Neurologists and PCPs

Author:Finnegan, Thomas   Merlo, Kathryn   Halker Singh, Rashmi   

Session Name:P8: Headache: Innovation, Quality and Technology  

Topic:Headache  

Program Number:P8.011  

Author Institution:Medscape Education, Newtown Square, PA  Medscape Education, Newark , NV  Mayo Clinic, Scottsdale, AZ  

Pregnancy Seizure Outcomes for Epilepsy Patients with Catamenial Seizure Exacerbation

Author:Voinescu, Paula   Lemus Esquivel, Hernan Nicolas   Liu, Lena   Allien, Stephanie   Pennell, Page   

Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Women with Epilepsy 1  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:P8.011  

Author Institution:Brigham and Women's Hospital, Boston, MA  University of Pittsburgh School of Medicine, Pittsburgh, PA  

PRAX-562-101: A Phase?1 Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Food Effect of PRAX-562 in Healthy Volunteers

Author:Pfister, Brian   Mahalingam, Rajeshwari   Oldham, Michael   Patel, Dharit   Jacotin, Henry   Hard, Marjie   Puryear, Corey   Ravina, Bernard   Souza, Marcio   Petrou, Steven   

Session Name:P8: Child Neurology and Developmental Neurology: Seizures 3  

Topic:Child Neurology and Developmental Neurology  

Program Number:P8.011  

Author Institution:Praxis Precision Medicines, Boston, MA  

Ocrelizumab and Cladribine had similar EDSS stability and safety profile in patients with highly active multiple sclerosis

Author:Alshawaf, Fatemah   Ahmed, Samar   Al-Hashel, Jasem   Alroughani, Raed   

Session Name:P8: MS Therapeutics 2  

Topic:MS and Inflammatory Disease  

Program Number:P8.011  

Author Institution:Kuwait Institute for Medical Specializations (KIMS), Kuwait, Kuwait  Ministry of health, Al-Minia, Egypt  Ministry of health, Sulibekhat, Kuwait  Ministry of health, Kuwait, Kuwait  

Efficacy of Omaveloxolone in Friedreich’s Ataxia: Post-Hoc Analysis Using Global Statistics Test to Strengthen Secondary Endpoint Analyses

Author:Hendrix, Suzanne   Goldsberry, Angie   Meyer, Colin   Lynch, David   

Session Name:P8: Movement Disorders: Ataxias 1  

Topic:Movement Disorders  

Program Number:P8.011  

Author Institution:Pentara Corporation, Salt Lake City, UT  Reata Pharmaceuticals Inc., Plano, TX  Children's Hospital of Philadelphia, Philadelphia, PA